Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (6): 379-380.
Previous Articles Next Articles
WANG Aming, WU Hui, WANG Hongxia, ZHANG Linlin, BIAN Hailin*
Received:2019-07-12
Revised:2019-07-12
Online:2019-06-20
Published:2019-07-12
CLC Number:
WANG Aming, WU Hui, WANG Hongxia, ZHANG Linlin, BIAN Hailin. One Case of Cytopenia Induced by Piperacillin Sodium and Tazobactam Sodium for Injection[J]. Chinese Journal of Pharmacovigilance, 2019, 16(6): 379-380.
| [1] 黄佳,白婕,赵志刚. 抗菌药物血脑屏障通透能力概述[J]. 药品评价,2012,9(35):32-36. [2] Uzun G,Onem Y,Hatipoglu M,et al.Piperacillin/tazobactam-induced neutropenia, thrombocytopenia and fever during treatment of a diabetic foot infection[J].Scand J Infect Dis, 2013, 45(1) :73-76. [3] 刘静,严郁,徐铤. 注射用哌拉西林钠他唑巴坦钠致白细胞减少及高热1例[J]. 中国药业,2015,24(13):95-95. [4] 黄丽,罗圣平,谭秋红. 注射用哌拉西林钠他唑巴坦钠致血小板减少1例[J]. 中国药物警戒,2016,13(5):313-314. [5] 张赞玲,尹桃. 静脉滴注哌拉西林钠-他唑巴坦钠致白细胞、血小板减少1例[J]. 中南药学,2006,4(6):474-474. [6] 尤冬梅. 全血细胞减少病因学探讨[J]. 国际检验医学杂志,2016,379(10):1445-1446. [7] Neftel K A, Hause S P, Müller M R.Inhibition of granulopoiesis in vivo and in vitro by beta-lactam antibiotics[J]. J Infect Dis, 1985, 152(1):90-98. [8] 赵业清,徐传新. 哌拉西林/他唑巴坦致不良反应23例文献分析[J]. 中国药房,2014,25(16):1501-1503. [9] Scheetz M H,McKoy J M,Parada J P,et al. Systematic Review of Piperacillin-Induced Neutropenia[J]. Drug Saf, 2007, 30(4):295-306. [10] 杨媛,张威,毛璐,等. 哌拉西林钠他唑巴坦钠致白细胞减少的临床特征分析[J]. 中国医院药学杂志,2014,34(7):550-552. [11] Peralta F G, Sánchez M B, Roíz M P, et al.Incidence of neutropenia during treatment of bone-related infections with piperacillin-tazobactam[J]. Clin Infect Dis, 2003, 37(11):1568-1572. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
